Filing Details
- Accession Number:
- 0001127602-10-006021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-23 12:00:00
- Reporting Period:
- 2010-02-19
- Filing Date:
- 2010-02-23
- Accepted Time:
- 2010-02-23 20:29:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1190637 | F James Barlow | 2525 Dupont Drive Irvine CA 92612 | Sr. Vp, Corp. Controller (Pao) | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-02-19 | 100 | $59.54 | 13,730 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-02-19 | 200 | $59.54 | 13,530 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-02-19 | 700 | $59.54 | 12,830 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-02-22 | 91 | $0.00 | 12,921 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2010-02-22 | 2,000 | $0.00 | 14,921 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2010-02-22 | 19,700 | $0.00 | 19,700 | $59.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,700 | 2020-02-22 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,301 | Indirect | By 401(k) Trust |
| Common Stock | 637 | Indirect | By Esop Trust |
Footnotes
- Award of Restricted Stock under the 2009 Managment Bonus Plan.
- Exempt Award of Restricted Stock.
- The option becomes exercisable in four equal annual installments beginning February 22, 2011.
Billionaire Hedge Funds
